Bonn, Germany

Christoph Coch

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Rheinische Friedrich-Wilhelms-Universitaet Bonn. Active years: 2021.


% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christoph Coch: Innovator in Extracellular Vesicle Research

Introduction

Christoph Coch is a notable inventor based in Bonn, Germany. He has made significant contributions to the field of biomedical research, particularly in the area of extracellular vesicles and their applications in treating diseases.

Latest Patents

Coch holds a patent for "Cell derived extracellular vesicles for the treatment of diseases." This invention pertains to extracellular vesicles, specifically exosomes, produced by culturing tumor cells in the presence of various ligands or activators of innate immunity receptors. The process involves isolating and purifying these vesicles from the culture supernatant. The invention also includes pharmaceutical compositions that utilize these exosomes as medicaments, particularly for the treatment of cancer diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Christoph Coch has been associated with the Rheinische Friedrich-Wilhelms-Universität Bonn, where he has conducted extensive research in his field. His work has contributed to advancing the understanding of extracellular vesicles and their potential therapeutic applications.

Collaborations

Coch has collaborated with notable colleagues, including Juliane Dassler-Plenker and Gunther Hartmann. These collaborations have further enriched his research and innovation in the field.

Conclusion

Christoph Coch's work in the development of extracellular vesicles for disease treatment exemplifies the innovative spirit of modern biomedical research. His contributions are paving the way for new therapeutic strategies in cancer treatment.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…